Alpha Mark Advisors, LLC Sorrento Therapeutics, Inc. Transaction History

Alpha Mark Advisors, LLC

  • $290 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 19, 2024
SELL
N/A
-1,000 Reduced 31.9%
2,135 $0
Q4 2022

Feb 06, 2023
SELL
$0.74 - $1.83 $640 - $1,582
-865 Reduced 21.63%
3,135 $3,000
Q1 2022

May 02, 2022
BUY
$2.0 - $4.9 $5,000 - $12,250
2,500 Added 166.67%
4,000 $9,000
Q4 2021

Feb 09, 2022
BUY
$4.65 - $7.23 $6,975 - $10,845
1,500 New
1,500 $7,000

Others Institutions Holding SRNE

# of Institutions
12
Shares Held
5.47M
Call Options Held
0
Put Options Held
0
View Full List

About Sorrento Therapeutics, Inc.

SRNE Quotes by TradingView
  • Ticker SRNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 449,952,000
  • Market Cap $148M
  • Description
  • Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...
More about SRNE
Track This Portfolio

Track Alpha Mark Advisors, LLC Portfolio

Follow Alpha Mark Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Mark Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Mark Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email